🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Diffuse Cutaneous Systemic Sclerosis

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study NCT07090226NA1 site📍 Boston Boston University · Tests: Spatial-frequency domain imaging (SFDI) Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis NCT06375005Phase 29 sites📍 Yangzhou📍 Shanghai📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Telitacicept, Mycophenolate Mofetil Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate NCT06936215Phase 31 site📍 Dhaka Bangabandhu Sheikh Mujib Medical University, Dhaka, Banglad… · Tests: tab baricitinib 4 mg daily, tab methotrexate 25 mg weekly with folic acid 5 mg weekly Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma NCT07256418n/a1 site📍 Dijon Centre Hospitalier Universitaire Dijon · Tests: Skin samples, Analysis of fibroblasts Maternal Autoimmune Disease Research Alliance (MADRA) Registry NCT03276923n/a1 site📍 Durham Duke University A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease NCT06925542Phase 117 sites📍 La Jolla📍 Redwood City📍 Chicago CRISPR Therapeutics · Tests: CTX112 Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases NCT06387654n/a1 site📍 Toulouse University Hospital, Toulouse · Tests: Blood sampling, Remainders of samples taken as part of the treatment Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults NCT07000916n/a1 site📍 Brussels Université Catholique de Louvain A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis NCT07047690Phase 23 sites📍 Ann Arbor📍 Arlington📍 Sankt Gallen Galderma R&D · Tests: Nemolizumab, Placebo A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE) NCT06716606Phase 341 sites📍 Los Angeles📍 New York📍 Philadelphia GlaxoSmithKline · Tests: Belimumab Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis NCT04986605Phase 21 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Extracorporeal Photopheresis (ECP), UVADEX Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis NCT03630211Phase 23 sites📍 Pittsburgh📍 Pittsburgh📍 Pittsburgh Paul Szabolcs · Tests: Cyclophosphamide, Mesna, Rituximab, Alemtuzumab, Thiotepa EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc) NCT07287670Phase 258 sites📍 Phoenix📍 La Jolla📍 Loma Linda Mediar Therapeutics · Tests: MTX-474, Placebo US Zamto-cel Autoimmune Diseases NCT06708845Phase 11 site📍 Milwaukee Miltenyi Biomedicine GmbH · Tests: zamtocabtagene autoleucel, Cyclophosphamide, Fludarabine Controlling Hyperactive Immunity With Long-lived Lymphocytes NCT07473154Phase 1, Phase 210 sites📍 Düsseldorf📍 Erlangen📍 Madrid Quell Therapeutics Limited · Tests: QEL-005
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy